Profitability
by Company within Major Pharmaceutical Preparations Industry
|
| Company |
Quarter |
Gross Margin |
Net Margin |
Cash flow Margin |
ROE |
| Aadi Bioscience Inc |
2 Q |
87.41% |
-236.01% |
-204.58% |
-66.67% |
| Abbvie Inc |
2 Q |
70.94% |
9.49% |
-34.14% |
57.23% |
| Abcellera Biologics Inc |
2 Q |
- |
-504.3% |
- |
-13.4% |
| Abeona Therapeutics Inc |
1 Q |
- |
-3745.91% |
- |
-821.46% |
| American Bio Medica Corporation |
1 Q |
45.12% |
- |
20.73% |
- |
| Abbott Laboratories |
2 Q |
55.64% |
12.55% |
6.77% |
15.08% |
| Arbutus Biopharma Corp |
2 Q |
- |
-1146.93% |
- |
-60.98% |
| Abvc Biopharma Inc |
2 Q |
99.84% |
-1086.45% |
71.51% |
-182.21% |
| Abivax Sa |
4 Q |
- |
- |
- |
-75.37% |
| Acadia Pharmaceuticals Inc |
3 Q |
93.09% |
-30.79% |
-5.71% |
-38.84% |
| Acer Therapeutics Inc |
3 Q |
77.46% |
-3962.25% |
-257.88% |
- |
| Adicet Bio Inc |
3 Q |
- |
- |
- |
-57.66% |
| Ac Immune Sa |
4 Q |
- |
-366.41% |
- |
-33.76% |
| Aclaris Therapeutics Inc |
2 Q |
77.44% |
-397.18% |
-470.25% |
-39.83% |
| Acrivon Therapeutics Inc |
3 Q |
- |
- |
- |
-20.66% |
| Acasti Pharma Inc |
3 Q |
- |
- |
- |
-54.53% |
| Actuate Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Accustem Sciences Inc |
2 Q |
- |
- |
- |
- |
| Acurx Pharmaceuticals inc |
2 Q |
- |
- |
- |
-371.2% |
| Adagene Inc |
4 Q |
- |
-104.61% |
0% |
-26.85% |
| Adc Therapeutics Sa |
2 Q |
- |
-209.9% |
- |
- |
| Adial Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-230.01% |
| Aditxt Inc |
2 Q |
47.75% |
-17218.99% |
5.76% |
-1887.97% |
| Addex Therapeutics Ltd |
4 Q |
- |
-654.47% |
- |
-921.57% |
| Ayala Pharmaceuticals Inc |
4 Q |
- |
- |
- |
- |
| Aeon Biopharma inc |
2 Q |
- |
- |
- |
- |
| Aeterna Zentaris Inc |
4 Q |
95.06% |
-367.99% |
- |
-31.24% |
| Kaya Holdings Inc |
2 Q |
- |
- |
- |
- |
| Affimed N v |
4 Q |
- |
-1280.22% |
- |
-183.26% |
| Agios Pharmaceuticals Inc |
2 Q |
82.65% |
-1115.71% |
-397.52% |
-47.05% |
| Agile Therapeutics Inc |
2 Q |
80.31% |
-233.7% |
4.59% |
- |
| Ainos Inc |
1 Q |
-29.07% |
-15991.17% |
-4123.35% |
-55.38% |
| Akebia Therapeutics Inc |
2 Q |
60.94% |
-19.66% |
-5.62% |
- |
| Akero Therapeutics Inc |
3 Q |
- |
- |
- |
-26.11% |
| Akari Therapeutics Plc |
4 Q |
- |
- |
- |
-991.1% |
| Akouos inc |
3 Q |
- |
- |
- |
-45.09% |
| Albireo Pharma inc |
3 Q |
93.78% |
-384.46% |
- |
-97.59% |
| Aldeyra Therapeutics Inc |
3 Q |
- |
- |
- |
-33.77% |
| Alimera Sciences Inc |
2 Q |
88.54% |
-12.65% |
-13.32% |
-33.7% |
| Alkermes Plc |
3 Q |
83.85% |
12.54% |
-4.75% |
18.33% |
| Allakos Inc |
3 Q |
- |
- |
- |
-62.29% |
| Allarity Therapeutics Inc |
2 Q |
- |
- |
- |
-647.16% |
| Alnylam Pharmaceuticals Inc |
2 Q |
89.8% |
-2.56% |
43.42% |
- |
| Alpine Immune Sciences Inc |
1 Q |
- |
-254.81% |
-155.08% |
-14.86% |
| Aileron Therapeutics Inc |
3 Q |
- |
- |
- |
-90.99% |
| Altimmune inc |
2 Q |
- |
-492800% |
-437000% |
-60.51% |
| Alt5 Sigma Corporation |
2 Q |
52.34% |
28.07% |
- |
-206.63% |
| Alx Oncology Holdings Inc |
3 Q |
- |
- |
- |
-65.99% |
| Alzamend Neuro Inc |
2 Q |
- |
- |
- |
- |
| Amylyx Pharmaceuticals Inc |
3 Q |
94.92% |
20.35% |
-109.55% |
0.49% |
| Ampio Pharmaceuticals inc |
4 Q |
- |
- |
- |
-149% |
| Amphastar Pharmaceuticals Inc |
1 Q |
52.43% |
25.13% |
33.09% |
24.79% |
| Amarin Corp Plcuk |
3 Q |
45.15% |
-29.23% |
57.25% |
-9.12% |
| Amneal Pharmaceuticals Inc |
1 Q |
36.12% |
-12.39% |
-7.21% |
-184.1% |
| Applied Molecular Transport Inc |
3 Q |
- |
- |
- |
-223.46% |
| Anaptysbio inc |
2 Q |
- |
-425.3% |
- |
-255.67% |
| Anebulo Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-138.92% |
| Ani Pharmaceuticals Inc |
2 Q |
58.2% |
-1.66% |
8.34% |
6.1% |
| Anixa Biosciences Inc |
2 Q |
- |
- |
- |
-53.94% |
| Adlai Nortye Ltd |
4 Q |
- |
-2097.42% |
0% |
-132.07% |
| Annexon Inc |
3 Q |
- |
- |
- |
-71.47% |
| Alto Neuroscience Inc |
2 Q |
- |
- |
- |
- |
| An2 Therapeutics Inc |
3 Q |
- |
- |
- |
-58.99% |
| Annovis Bio Inc |
2 Q |
- |
- |
- |
- |
| Apexigen Inc |
2 Q |
- |
- |
- |
-910.95% |
| Apellis Pharmaceuticals Inc |
3 Q |
- |
-127.03% |
-148.41% |
-209.04% |
| Applied Therapeutics Inc |
2 Q |
- |
- |
-16865.97% |
-577.92% |
| Aptorum Group Limited |
4 Q |
2.45% |
-1006.3% |
- |
-28.22% |
| Aprea Therapeutics Inc |
2 Q |
- |
-617.92% |
-653.55% |
-56.38% |
| Aptinyx Inc |
1 Q |
- |
- |
- |
-157.89% |
| Aptevo Therapeutics Inc |
3 Q |
- |
- |
- |
-89.48% |
| Aquestive Therapeutics Inc |
2 Q |
77.48% |
-13.66% |
-26.52% |
- |
| Aravive Inc |
3 Q |
- |
- |
-1639.73% |
- |
| Arcturus Therapeutics Holdings Inc |
3 Q |
- |
-35.94% |
-25.58% |
34.11% |
| Aridis Pharmaceuticals Inc |
4 Q |
- |
-526.55% |
- |
- |
| Ardelyx inc |
2 Q |
87.11% |
-22.47% |
7.84% |
-36.21% |
| Arcutis Biotherapeutics Inc |
2 Q |
88.77% |
-339.18% |
-342.95% |
31.45% |
| Artelo Biosciences Inc |
2 Q |
- |
- |
- |
-96.72% |
| Arvinas Inc |
2 Q |
- |
-46.01% |
87.32% |
-55.59% |
| Arrowhead Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-169.04% |
| Aslan Pharmaceuticals Limited |
4 Q |
- |
- |
- |
-377.64% |
| Assembly Biosciences Inc |
3 Q |
- |
- |
- |
-116.42% |
| Ascendis Pharma A |
4 Q |
76.28% |
-1139.63% |
- |
-221.45% |
| Assertio Holdings inc |
2 Q |
71.44% |
-11.8% |
-115.68% |
-231.03% |
| Atai Life Sciences N v |
3 Q |
- |
- |
-74250.57% |
-28.83% |
| Alterity Therapeutics Limited |
2 Q |
- |
- |
- |
0% |
| Athersys Inc |
3 Q |
- |
- |
- |
- |
| 180 Life Sciences Corp |
2 Q |
- |
- |
- |
-1155.47% |
| Actinium Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-102.88% |
| Athenex Inc |
4 Q |
75.22% |
-425.38% |
-143.85% |
- |
| Atossa Therapeutics Inc |
3 Q |
- |
- |
- |
-27.47% |
| Adhera Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Avenue Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Astria Therapeutics Inc |
2 Q |
- |
- |
- |
-32.65% |
| Aurinia Pharmaceuticals Inc |
2 Q |
84.42% |
1.26% |
-54.29% |
-13.48% |
| Arrivent Biopharma inc |
2 Q |
- |
- |
- |
- |
| Avadel Pharmaceuticals Plc |
2 Q |
95.09% |
-33.95% |
-17.06% |
-141.16% |
| Aveo Pharmaceuticals Inc |
3 Q |
86.98% |
-10.73% |
23.74% |
-81.66% |
| Atea Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-21.49% |
| Avenir Wellness Solutions Inc |
1 Q |
68% |
-467% |
46.69% |
- |
| Aerovate Therapeutics Inc |
2 Q |
- |
- |
- |
-10.3% |
| Avalo Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Axim Biotechnologies Inc |
2 Q |
90.02% |
-12985.95% |
-518.72% |
- |
| Axsome Therapeutics Inc |
3 Q |
88.7% |
-107.62% |
-35.56% |
-104.89% |
| Aytu Biopharma Inc |
2 Q |
62.97% |
-24.42% |
1.3% |
-51.31% |
| Astrazeneca Plc |
4 Q |
81.95% |
13.01% |
13.46% |
15.22% |
| Azitra Inc |
2 Q |
- |
-35093.24% |
-29295.49% |
-347.49% |
| Bridgebio Pharma Inc |
3 Q |
85.38% |
-4387.39% |
- |
- |
| Atreca inc |
3 Q |
- |
- |
- |
-200.73% |
| Briacell Therapeutics Corp |
1 Q |
- |
- |
- |
- |
| Bicycle Therapeutics Plc |
2 Q |
- |
-425.3% |
- |
-32.8% |
| Bioadaptives Inc |
2 Q |
-63.56% |
-27113.63% |
-2868.15% |
- |
| Biodexa Pharmaceuticals Plc |
4 Q |
- |
-1858.01% |
0% |
-151.33% |
| Bullfrog Ai Holdings Inc |
1 Q |
- |
- |
- |
-131.39% |
| Biofrontera Inc |
1 Q |
68.14% |
-84.28% |
19.98% |
-480.7% |
| Beigene Ltd |
2 Q |
85.15% |
-12.96% |
-20.4% |
-14.93% |
| Bausch Health Companies Inc |
2 Q |
70.54% |
-0.04% |
-5.49% |
- |
| Biohaven Ltd |
2 Q |
- |
- |
- |
-203.22% |
| Biora Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Biovie Inc |
2 Q |
- |
- |
- |
-259.71% |
| Bioxytran Inc |
2 Q |
- |
- |
- |
- |
| Bellicum Pharmaceuticals Inc |
3 Q |
- |
-76.15% |
-1589.62% |
- |
| Bellerophon Therapeutics inc |
3 Q |
- |
- |
- |
-164.63% |
| Biolinerx Ltd |
4 Q |
23.08% |
-1262.79% |
- |
-458.4% |
| Belite Bio Inc |
4 Q |
- |
- |
- |
-34.98% |
| Biomea Fusion Inc |
3 Q |
- |
- |
- |
-69.97% |
| Biomarin Pharmaceutical Inc |
2 Q |
81.68% |
15.05% |
31.62% |
5.08% |
| Bristol myers Squibb Company |
2 Q |
73.22% |
13.8% |
-24.9% |
-28.33% |
| Bionomics Limited |
2 Q |
- |
-144450.3% |
0% |
-96.08% |
| Benitec Biopharma Inc |
2 Q |
- |
- |
- |
-92.7% |
| Bolt Biotherapeutics Inc |
3 Q |
- |
-643.08% |
-161.83% |
-47.56% |
| Blueprint Medicines Corporation |
2 Q |
94.5% |
-36.19% |
-42.24% |
-85.25% |
| Bio path Holdings Inc |
2 Q |
- |
- |
- |
-2842.4% |
| Biophytis Sa |
4 Q |
- |
- |
- |
- |
| Barinthus Biotherapeutics Plc |
2 Q |
- |
- |
- |
0% |
| Bespoke Extracts Inc |
2 Q |
38.15% |
-93.79% |
3.73% |
- |
| Bioxcel Therapeutics Inc |
2 Q |
94.38% |
-751.72% |
-1618.66% |
- |
| Biostax Corp |
2 Q |
- |
- |
- |
- |
| Blue Water Vaccines Inc |
2 Q |
14.29% |
-2029.76% |
-501.29% |
- |
| Baudax Bio Inc |
3 Q |
- |
- |
- |
- |
| Beyondspring Inc |
4 Q |
- |
-2685.42% |
-5026.79% |
- |
| Calithera Biosciences Inc |
4 Q |
- |
- |
- |
-107.94% |
| Calcimedica Inc |
3 Q |
- |
- |
- |
-174.2% |
| Calliditas Therapeutics Ab |
4 Q |
95.36% |
-38.78% |
- |
-4.97% |
| Can fite Biopharma Ltd |
4 Q |
- |
-1255.93% |
-478.77% |
-224.17% |
| Capricor Therapeutics inc |
2 Q |
- |
-276.97% |
- |
-220.26% |
| Cara Therapeutics inc |
2 Q |
-50.25% |
-2019.78% |
- |
-241.31% |
| Carisma Therapeutics Inc |
2 Q |
- |
-242.73% |
-175.63% |
-582.41% |
| Casi Pharmaceuticals inc |
4 Q |
59.19% |
-77.51% |
58.57% |
-108.67% |
| Cymabay Therapeutics Inc |
4 Q |
- |
-73512.28% |
-117119.3% |
-50.72% |
| Catalyst Biosciences Inc |
3 Q |
- |
- |
- |
- |
| Chemocentryx Inc. |
2 Q |
96.59% |
-134.54% |
16.23% |
-48.52% |
| Avid Bioservices Inc |
2 Q |
14.22% |
-13.78% |
-11.76% |
-119.38% |
| Conduit Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Celularity Inc |
3 Q |
85.29% |
-2479.56% |
-74.25% |
-144.18% |
| Chembio Diagnostics Inc |
4 Q |
45.78% |
-8.27% |
-27.8% |
-113.57% |
| Cen Biotech Inc |
3 Q |
- |
-264.15% |
-94.3% |
- |
| Cerevel Therapeutics Holdings Inc |
3 Q |
- |
- |
- |
-99.72% |
| Contrafect Corporation |
3 Q |
- |
- |
- |
- |
| China Health Industries Holdings Inc |
1 Q |
0% |
-164082.76% |
- |
-7.45% |
| Cincor Pharma Inc |
3 Q |
- |
- |
- |
0% |
| Cingulate Inc |
4 Q |
- |
- |
- |
- |
| Checkpoint Therapeutics inc |
2 Q |
- |
-16268.29% |
-15341.46% |
- |
| Cell Source Inc |
2 Q |
- |
- |
- |
- |
| Clene Inc |
2 Q |
80.22% |
-7456.04% |
-54.95% |
-315.97% |
| Cellectar Biosciences Inc |
1 Q |
- |
- |
- |
-2167.93% |
| Clearside Biomedical Inc |
3 Q |
83.47% |
-1078.81% |
-722.12% |
- |
| Clever Leaves Holdings Inc |
4 Q |
-7.05% |
-103.56% |
7.39% |
-57.45% |
| Clovis Oncology inc |
3 Q |
76.31% |
-182.68% |
-118.25% |
- |
| Chemomab Therapeutics Ltd |
4 Q |
- |
- |
- |
142.5% |
| Clearmind Medicine Inc |
3 Q |
- |
- |
- |
-876.57% |
| Compass Pathways Plc |
2 Q |
- |
- |
- |
-57.74% |
| Comera Life Sciences Holdings Inc |
3 Q |
69.22% |
-1580.01% |
- |
- |
| Chimerix inc |
2 Q |
- |
-16034.88% |
-2610.85% |
-46.35% |
| Cnbx Pharmaceuticals Inc |
2 Q |
- |
- |
- |
- |
| Concert Pharmaceuticals Inc |
3 Q |
- |
-361300% |
-550700% |
-165.03% |
| Cns Pharmaceuticals Inc |
2 Q |
- |
- |
- |
- |
| Centessa Pharmaceuticals Plc |
2 Q |
- |
- |
- |
-63.08% |
| Connect Biopharma Holdings Limited |
4 Q |
- |
- |
- |
-58.89% |
| Context Therapeutics Inc |
2 Q |
- |
- |
- |
-53.12% |
| Cocrystal Pharma Inc |
2 Q |
- |
- |
- |
-64.9% |
| Cogent Biosciences Inc |
3 Q |
- |
- |
- |
-62.85% |
| Collegium Pharmaceutical inc |
2 Q |
62.71% |
13.54% |
-38.48% |
49.14% |
| Corcept Therapeutics Inc |
2 Q |
98.46% |
21.44% |
-12.92% |
23.66% |
| Coya Therapeutics Inc |
3 Q |
- |
- |
- |
0% |
| China Pharma Holdings Inc |
2 Q |
-109.78% |
-155.48% |
-10.76% |
-57.55% |
| Cumberland Pharmaceuticals Inc |
2 Q |
82.63% |
-11.2% |
-12.31% |
-35.11% |
| Cannapharmarx Inc |
2 Q |
- |
- |
- |
- |
| Catalyst Pharmaceuticals Inc |
1 Q |
87.29% |
23.63% |
- |
15.57% |
| Corbus Pharmaceuticals Holdings Inc |
3 Q |
- |
- |
- |
-320.25% |
| Cormedix Inc |
2 Q |
36.75% |
-1755.51% |
-3139.04% |
-78.73% |
| Crinetics Pharmaceuticals Inc |
3 Q |
- |
-16606.36% |
- |
-57.04% |
| Cervomed Inc |
2 Q |
- |
-70.44% |
- |
-4.42% |
| Corvus Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-53.99% |
| Cti Biopharma Corp |
1 Q |
94.92% |
-55.66% |
-25.75% |
- |
| Innovation Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-116.47% |
| Catalent Inc |
2 Q |
29.52% |
1.77% |
9.76% |
-28.3% |
| Cytomx Therapeutics Inc |
3 Q |
- |
11.34% |
-119.44% |
- |
| Contineum Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Citius Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-46.37% |
| Cue Biopharma Inc |
3 Q |
- |
-524.05% |
85.24% |
-99.14% |
| Curevac N v |
4 Q |
-131.34% |
-483.96% |
57.08% |
-50.33% |
| Cadrenal Therapeutics Inc |
2 Q |
- |
- |
- |
0% |
| Cv Sciences Inc |
3 Q |
47.96% |
-11.63% |
-1.22% |
56.96% |
| Cohbar Inc |
2 Q |
- |
- |
- |
-88.89% |
| Celyad Oncology Sa |
4 Q |
- |
- |
- |
-614.13% |
| Cybin Inc |
1 Q |
- |
-84.08% |
0% |
-26.75% |
| Cyclacel Pharmaceuticals Inc |
2 Q |
- |
-81425% |
- |
-855% |
| Cyclerion Therapeutics Inc |
1 Q |
- |
-1825.32% |
-1805.34% |
-99.04% |
| Cytodyn Inc |
2 Q |
- |
- |
- |
- |
| Cryoport inc |
2 Q |
43.73% |
-138.88% |
-5.56% |
-38.03% |
| Cyteir Therapeutics Inc |
3 Q |
- |
- |
- |
-24.88% |
| Cytokinetics Incorporated |
3 Q |
- |
-34238.62% |
- |
- |
| Altamira Therapeutics Ltd |
4 Q |
- |
- |
- |
- |
| Dare Bioscience Inc |
2 Q |
- |
- |
- |
- |
| Day One Biopharmaceuticals Inc |
3 Q |
- |
- |
- |
-7.66% |
| Decibel Therapeutics Inc |
2 Q |
- |
- |
- |
-84.03% |
| Deciphera Pharmaceuticals Inc |
1 Q |
95.36% |
-100.19% |
19.04% |
-52.42% |
| Journey Medical Corp |
2 Q |
55.97% |
-22.63% |
-0.98% |
5.44% |
| Dice Therapeutics Inc |
2 Q |
- |
- |
- |
-22.01% |
| Diamedica Therapeutics Inc |
2 Q |
- |
- |
- |
-38.56% |
| Dmk Pharmaceuticals Corporation |
3 Q |
-3635.25% |
-15317.21% |
- |
- |
| Dianthus Therapeutics Inc |
3 Q |
- |
-1597.73% |
- |
-61.77% |
| Dermata Therapeutics Inc |
2 Q |
- |
- |
- |
-197.44% |
| Durect Corp |
3 Q |
82.11% |
-172.88% |
- |
-243.4% |
| Bright Minds Biosciences Inc |
3 Q |
- |
- |
- |
-111.73% |
| Design Therapeutics Inc |
3 Q |
- |
- |
- |
-23.69% |
| Dynavax Technologies Corporation |
3 Q |
80.69% |
20.86% |
-105.46% |
10.46% |
| Dyne Therapeutics Inc |
3 Q |
- |
- |
- |
-97.57% |
| Emergent Biosolutions Inc |
2 Q |
-16.25% |
-111.15% |
-3.14% |
-98.52% |
| Edesa Biotech Inc |
2 Q |
- |
- |
- |
-137.98% |
| Effector Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Eagle Pharmaceuticals inc |
2 Q |
73.92% |
7.99% |
-10.12% |
4.98% |
| Elevai Labs Inc |
2 Q |
66.01% |
-141.18% |
-122.25% |
- |
| Elanco Animal Health Inc |
2 Q |
58.19% |
-4.22% |
6% |
-20.61% |
| Eledon Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-101.74% |
| Elite Pharmaceuticals Inc |
2 Q |
45.87% |
3.33% |
7.07% |
37.78% |
| Elicio Therapeutics Inc |
2 Q |
- |
- |
- |
-604.87% |
| Enliven Therapeutics Inc |
3 Q |
- |
- |
- |
-8.69% |
| Eliem Therapeutics Inc |
3 Q |
- |
- |
- |
-33.55% |
| Emmaus Life Sciences Inc |
3 Q |
95.74% |
1.34% |
2.87% |
- |
| Endo International Plc |
4 Q |
49.87% |
-490.52% |
-9.17% |
- |
| Enlivex Therapeutics Ltd |
4 Q |
- |
- |
- |
-96.62% |
| Ensysce Biosciences Inc |
2 Q |
- |
-1082.41% |
-1298.77% |
-182.22% |
| Enanta Pharmaceuticals Inc |
3 Q |
- |
-148.46% |
-51.71% |
-52.23% |
| Enveric Biosciences Inc |
1 Q |
- |
- |
- |
-382.97% |
| Evolus Inc |
2 Q |
71.49% |
-16.96% |
-4.91% |
- |
| Essa Pharma inc |
2 Q |
- |
- |
- |
-20.17% |
| Epizyme Inc. |
2 Q |
81.22% |
-129.85% |
-23.09% |
- |
| Equillium Inc |
3 Q |
- |
-41.83% |
98.74% |
-29.28% |
| Eqrx Inc |
3 Q |
- |
- |
- |
-20.27% |
| Erasca Inc |
3 Q |
- |
- |
- |
-58.93% |
| Eterna Therapeutics Inc |
2 Q |
-102.13% |
-11763.83% |
-5382.98% |
- |
| Esperion Therapeutics Inc |
2 Q |
- |
-83.87% |
-50.53% |
- |
| 89bio Inc |
3 Q |
- |
- |
- |
-34.92% |
| Eton Pharmaceuticals Inc |
2 Q |
65.22% |
-35.25% |
12.04% |
-43.62% |
| Earth Science Tech Inc |
1 Q |
64.11% |
3.61% |
7.65% |
41.48% |
| Entasis Therapeutics Holdings Inc |
1 Q |
- |
- |
- |
-145.48% |
| Evofem Biosciences Inc |
2 Q |
81.51% |
31.35% |
0.07% |
- |
| Evelo Biosciences Inc |
3 Q |
- |
- |
- |
- |
| Evotec Se |
4 Q |
22.4% |
-10.74% |
54.08% |
-7.49% |
| Evoke Pharma Inc |
3 Q |
- |
-108.39% |
-66.65% |
-517.96% |
| Edgewise Therapeutics inc |
2 Q |
- |
- |
- |
-28.01% |
| Eyenovia inc |
2 Q |
-2067.34% |
-48856.13% |
-25084% |
-615.55% |
| Fortress Biotech Inc |
2 Q |
56.09% |
-193.5% |
-50.84% |
- |
| Fibrobiologics Inc |
1 Q |
- |
- |
- |
- |
| Forte Biosciences Inc |
3 Q |
- |
- |
- |
-88.96% |
| Fibrogen Inc |
3 Q |
89.43% |
-158.51% |
-78.91% |
- |
| Foghorn Therapeutics Inc |
2 Q |
- |
-333.61% |
- |
- |
| Homology Medicines Inc |
3 Q |
- |
- |
- |
-97.6% |
| Flora Growth Corp |
1 Q |
21.37% |
-18.71% |
-1.08% |
-333.66% |
| Amicus Therapeutics inc |
2 Q |
91.3% |
-12.42% |
-0.35% |
-85.9% |
| Frequency Therapeutics Inc |
3 Q |
- |
- |
- |
-115.97% |
| F star Therapeutics Inc |
3 Q |
- |
-1636.18% |
-1470.4% |
-56.71% |
| Fulcrum Therapeutics Inc |
3 Q |
- |
-3164.3% |
-511.99% |
-38.48% |
| First Wave Biopharma Inc |
1 Q |
- |
- |
- |
-102.84% |
| Galectin Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Gain Therapeutics Inc |
2 Q |
- |
- |
- |
-214.2% |
| Generation Bio Co |
2 Q |
- |
-499.44% |
-225.15% |
-92.86% |
| Global Blood Therapeutics Inc. |
2 Q |
98.03% |
-115.26% |
-182.63% |
-170.37% |
| The Greater Cannabis Company Inc |
1 Q |
- |
- |
- |
- |
| Geron Corp |
3 Q |
- |
-27320.12% |
-15971.34% |
-70.26% |
| Gh Research Plc |
4 Q |
- |
- |
- |
-16.25% |
| Guardion Health Sciences Inc |
2 Q |
49.85% |
- |
- |
77.24% |
| Galmed Pharmaceuticals Ltd |
4 Q |
- |
- |
- |
49.8% |
| Galapagos Nv |
4 Q |
- |
88.31% |
0% |
7.57% |
| Gelesis Holdings Inc |
2 Q |
55.01% |
-693.86% |
- |
- |
| Greenwich Lifesciences Inc |
2 Q |
- |
- |
- |
-119.35% |
| Galecto Inc |
3 Q |
- |
- |
- |
-95.14% |
| Glycomimetics Inc |
2 Q |
- |
- |
- |
-148.49% |
| Genelux Corporation |
2 Q |
- |
- |
- |
-94.79% |
| Genprex Inc |
2 Q |
- |
- |
- |
-318.57% |
| Gossamer Bio Inc |
2 Q |
- |
51.37% |
50.1% |
-117.33% |
| Geovax Labs Inc |
2 Q |
- |
-1684.21% |
- |
-420.35% |
| Structure Therapeutics Inc |
2 Q |
- |
- |
- |
-20.12% |
| Gracell Biotechnologies Inc |
4 Q |
- |
- |
- |
-44.16% |
| Grifols Sa |
4 Q |
- |
- |
- |
2.27% |
| Gri Bio Inc |
2 Q |
- |
- |
- |
-321.18% |
| Galera Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Globestar Therapeutics Corporation |
2 Q |
- |
- |
- |
- |
| Gt Biopharma Inc |
2 Q |
- |
- |
- |
-160.47% |
| G1 Therapeutics Inc |
2 Q |
- |
-33.05% |
-29.09% |
-136.98% |
| Hutchmed china Limited |
4 Q |
60.38% |
12.06% |
-14.21% |
13.6% |
| Hcw Biologics Inc |
3 Q |
20.49% |
-578.9% |
- |
-64.43% |
| Hepion Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-328.66% |
| Humanigen Inc |
1 Q |
- |
-1892.31% |
-3194.12% |
- |
| Hookipa Pharma inc |
2 Q |
- |
-1480.23% |
-1206.36% |
-51.77% |
| Hoth Therapeutics Inc |
2 Q |
- |
- |
- |
-81.13% |
| Werewolf Therapeutics Inc |
2 Q |
- |
-1509.1% |
-2092.21% |
-48.25% |
| Inhibitor Therapeutics Inc |
1 Q |
- |
- |
- |
-59.43% |
| Harmony Biosciences Holdings inc |
2 Q |
81.47% |
6.71% |
-9.08% |
22.97% |
| Harrow Inc |
1 Q |
70.62% |
-39.86% |
-16.3% |
-54.95% |
| Heron Therapeutics Inc |
3 Q |
42.36% |
-80.09% |
68.52% |
- |
| Hst Global Inc |
2 Q |
- |
- |
- |
- |
| Histogen Inc |
3 Q |
- |
-77080% |
-53720% |
-136.2% |
| Fsd Pharma Inc |
4 Q |
- |
-392.95% |
- |
-138.68% |
| Horizon Therapeutics Public Limited Company |
2 Q |
76.8% |
13.46% |
16.21% |
8.54% |
| Ibio inc |
2 Q |
- |
-4968.57% |
- |
-126.49% |
| Intercept Pharmaceuticals inc |
3 Q |
99.78% |
-3.14% |
-37.96% |
-82.24% |
| Ideaya Biosciences Inc |
3 Q |
- |
-341.38% |
- |
-24.39% |
| Inflarx N v |
4 Q |
-743.67% |
-67630.69% |
- |
-41.59% |
| India Globalization Capital Inc |
2 Q |
59.93% |
-874.26% |
- |
-112.97% |
| Igm Biosciences Inc |
3 Q |
- |
-12178.59% |
- |
-91.73% |
| Intelgenx Technologies Corp |
1 Q |
- |
-2314.37% |
-1099.43% |
- |
| I mab |
4 Q |
- |
-5302.83% |
-4978.71% |
-85.31% |
| Immunogen inc |
3 Q |
- |
27.11% |
29.58% |
-22.11% |
| Imago Biosciences Inc |
3 Q |
- |
- |
- |
-13.66% |
| Immutep Limited |
2 Q |
- |
-767.22% |
- |
-29.23% |
| Immix Biopharma Inc |
4 Q |
- |
- |
- |
-102.67% |
| Immunome Inc |
1 Q |
- |
-12584.26% |
- |
-196.31% |
| Imunon Inc |
2 Q |
- |
- |
- |
-165.51% |
| Impel Pharmaceuticals Inc |
3 Q |
58.27% |
-288.21% |
-217.42% |
- |
| Immuron Limited |
2 Q |
88.43% |
-255.78% |
- |
-19.3% |
| Immuneering Corporation |
2 Q |
- |
- |
- |
-66.03% |
| Immunic Inc |
2 Q |
- |
- |
- |
-169.82% |
| Integrated Biopharma Inc |
2 Q |
8.99% |
1.88% |
-2.4% |
0.59% |
| Intercure Ltd |
4 Q |
29.56% |
-17.87% |
10.66% |
-13.9% |
| Indaptus Therapeutics Inc |
1 Q |
- |
- |
- |
-102.95% |
| Indivior Plc |
4 Q |
82.98% |
0.18% |
0% |
- |
| Infinity Pharmaceuticals Inc |
2 Q |
- |
-1707.72% |
- |
- |
| Inmed Pharmaceuticals Inc |
1 Q |
26.14% |
-119.19% |
- |
-77.75% |
| Insmed Inc |
2 Q |
69.82% |
-432.8% |
- |
- |
| Inozyme Pharma Inc |
3 Q |
- |
- |
- |
-55.93% |
| Io Biotech Inc |
3 Q |
- |
- |
- |
-60.91% |
| Ionis Pharmaceuticals Inc |
1 Q |
98.2% |
-119.5% |
-42.16% |
-108.79% |
| Immunoprecise Antibodies Ltd |
1 Q |
55.95% |
-128.53% |
0% |
-45.95% |
| Intellipharmaceutics International Inc |
4 Q |
- |
-4400.55% |
- |
- |
| Disc Medicine Inc |
3 Q |
- |
- |
- |
-26% |
| Ironwood Pharmaceuticals inc |
2 Q |
- |
-0.91% |
-16.97% |
- |
| International Stem Cell Corporation |
3 Q |
60.42% |
-6.64% |
2.43% |
- |
| Iveric Bio Inc |
1 Q |
- |
- |
- |
-57% |
| Intra cellular Therapies Inc |
2 Q |
- |
-10.05% |
- |
-11.48% |
| Iterum Therapeutics Plc |
3 Q |
- |
-29.37% |
-67.57% |
-216.28% |
| Inventiva S a |
4 Q |
- |
-271.72% |
- |
- |
| Incannex Healthcare Inc |
2 Q |
- |
- |
- |
- |
| Jaguar Health Inc |
2 Q |
84.31% |
-353.84% |
- |
-417.29% |
| Janux Therapeutics Inc |
3 Q |
- |
-459.59% |
-657.57% |
-19.56% |
| Jazz Pharmaceuticals Plc |
2 Q |
- |
16.46% |
-8.55% |
10.76% |
| Johnson and Johnson |
2 Q |
69.4% |
20.88% |
-2.65% |
54.01% |
| Kineta Inc |
3 Q |
- |
- |
- |
-1994.91% |
| Kala Bio inc |
2 Q |
- |
- |
- |
-396.03% |
| Kalvista Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-67.13% |
| Chinook Therapeutics Inc |
2 Q |
- |
-6641.27% |
- |
-58.28% |
| Kamada Ltd |
4 Q |
38.94% |
5.81% |
0% |
3.39% |
| Kiniksa Pharmaceuticals International Plc |
2 Q |
88.66% |
-3.6% |
-38.49% |
-2.39% |
| Kinnate Biopharma Inc |
3 Q |
- |
- |
- |
-62.31% |
| Kiora Pharmaceuticals Inc |
2 Q |
- |
-11108.23% |
-123504.21% |
15.57% |
| Karyopharm Therapeutics Inc |
3 Q |
97.47% |
-95.83% |
-103.49% |
- |
| Kronos Bio Inc |
2 Q |
- |
-602.68% |
- |
-68.82% |
| Keros Therapeutics Inc |
2 Q |
- |
-835.77% |
-675.53% |
-44.73% |
| Karuna Therapeutics Inc |
3 Q |
- |
- |
- |
-29.58% |
| Kintara Therapeutics Inc |
3 Q |
- |
- |
- |
-573.13% |
| Pasithea Therapeutics Corp |
1 Q |
- |
- |
- |
-48.05% |
| Kura Oncology Inc |
3 Q |
- |
- |
- |
-33.54% |
| Kazia Therapeutics Limited |
2 Q |
- |
-2046500% |
- |
-169.83% |
| Kezar Life Sciences Inc |
3 Q |
- |
-330.04% |
-23.01% |
-36.18% |
| Longboard Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-83.25% |
| Lannett Company Inc |
1 Q |
19.1% |
-127.69% |
-11.72% |
- |
| Legend Biotech Corporation |
4 Q |
49.42% |
-181.75% |
- |
-41.41% |
| Lexaria Bioscience Corp |
2 Q |
- |
-2124.18% |
- |
-121.02% |
| Lifecore Biomedical Inc |
3 Q |
22.09% |
-66.55% |
-12.06% |
98.73% |
| Lifevantage Corp |
2 Q |
79.55% |
2.67% |
-1% |
10.74% |
| Ligand Pharmaceuticals Incorporated |
2 Q |
80.12% |
-124.99% |
-76.94% |
3.6% |
| Longeveron Inc |
2 Q |
73.5% |
-2545.73% |
- |
-298.04% |
| Lianbio |
3 Q |
- |
- |
- |
-0.33% |
| Lftd Partners Inc |
2 Q |
37.46% |
-5.51% |
-8.04% |
-2.67% |
| Lipella Pharmaceuticals Inc |
2 Q |
- |
-687.63% |
-673.45% |
-172.04% |
| Lixte Biotechnology Holdings Inc |
4 Q |
- |
- |
- |
-129.68% |
| Eli Lilly And Company |
2 Q |
80.8% |
26.25% |
6.75% |
60.3% |
| Lipocine Inc |
4 Q |
- |
-2519.07% |
- |
-63.28% |
| Leap Therapeutics Inc |
2 Q |
- |
- |
- |
-98.01% |
| Liquidia Corporation |
2 Q |
59.2% |
-763.65% |
-676.82% |
-183.58% |
| Larimar Therapeutics Inc |
3 Q |
- |
- |
- |
-32.58% |
| Lakeshore Biopharma Co Ltd |
1 Q |
79.48% |
-75.59% |
0% |
-74.07% |
| Lucy Scientific Discovery Inc |
4 Q |
60.06% |
-27050.05% |
-273.59% |
-109.81% |
| Lisata Therapeutics Inc |
2 Q |
- |
- |
- |
-41.29% |
| Lantern Pharma Inc |
4 Q |
- |
- |
- |
-34.54% |
| Lumos Pharma Inc |
2 Q |
- |
-1547.34% |
-1307.38% |
-157.99% |
| Lexicon Pharmaceuticals Inc |
2 Q |
89.92% |
-3244.02% |
-3696.24% |
-106.17% |
| Lyell Immunopharma Inc |
2 Q |
- |
-352376.92% |
- |
-33.35% |
| Merrimack Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-15.88% |
| Maia Biotechnology Inc |
3 Q |
- |
- |
- |
-91.44% |
| Mustang Bio inc |
3 Q |
- |
- |
- |
-133.38% |
| Moleculin Biotech Inc |
2 Q |
- |
- |
- |
-100.16% |
| Seres Therapeutics Inc |
3 Q |
- |
-15436.77% |
-19228.71% |
- |
| Madrigal Pharmaceuticals Inc |
2 Q |
- |
-1038.2% |
-839.73% |
-95.61% |
| Medicenna Therapeutics Corp. |
1 Q |
- |
- |
- |
- |
| 23andme Holding Co |
2 Q |
51.92% |
-175.63% |
-112.41% |
-189.28% |
| Mei Pharma Inc |
3 Q |
- |
86.33% |
-20.73% |
87.24% |
| Macrogenics Inc |
2 Q |
98.37% |
-515.55% |
33.13% |
-106.84% |
| Mira Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-47.98% |
| Mirum Pharmaceuticals Inc |
2 Q |
74.03% |
-31.64% |
-89.05% |
-72.75% |
| Milestone Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-165.26% |
| Moonlake Immunotherapeutics |
2 Q |
- |
- |
- |
-11.17% |
| Mineralys Therapeutics Inc |
2 Q |
- |
- |
- |
-42.61% |
| Mallinckrodt Plc |
2 Q |
37.94% |
-8.42% |
4.77% |
31.06% |
| Mannkind Corporation |
3 Q |
79.98% |
3.36% |
-6.18% |
- |
| Medicinova Inc |
3 Q |
- |
-72.31% |
-136.89% |
-14.21% |
| Monopar Therapeutics Inc |
2 Q |
- |
- |
- |
-110.6% |
| Morphosys Ag |
4 Q |
75.51% |
-79.63% |
46.08% |
-386.82% |
| Morphic Holding inc |
2 Q |
- |
- |
- |
-26.62% |
| Medicure Inc |
4 Q |
64.48% |
-4.25% |
12.52% |
-4.63% |
| Mereo Biopharma Group Plc |
4 Q |
- |
- |
- |
20.57% |
| Merck and Co Inc |
2 Q |
76.76% |
33.89% |
35.39% |
33.75% |
| Marker Therapeutics inc |
2 Q |
- |
-187.53% |
-301.3% |
-79.39% |
| Marinus Pharmaceuticals Inc |
2 Q |
90.88% |
-444.74% |
-491.27% |
-1159.35% |
| Mersana Therapeutics inc |
2 Q |
- |
-1058.35% |
-705.97% |
-333.91% |
| Mirati Therapeutics Inc |
3 Q |
- |
-987.22% |
- |
-82.15% |
| Merus N v |
3 Q |
- |
-208.57% |
- |
-63.39% |
| Maravai Lifesciences Holdings Inc |
2 Q |
47.86% |
-19.74% |
15.64% |
-7.68% |
| Musclepharm Corporation |
1 Q |
11.52% |
-48.1% |
-5.26% |
- |
| Metacrine Inc |
3 Q |
- |
- |
- |
-83.77% |
| Molecular Templates Inc |
2 Q |
- |
-1415.56% |
- |
-807.85% |
| Matinas Biopharma Holdings Inc |
2 Q |
- |
- |
- |
-31.02% |
| Mural Oncology Plc |
3 Q |
- |
- |
- |
- |
| Mainz Biomed N v |
4 Q |
56.91% |
-2936.5% |
0% |
-809.29% |
| Myovant Sciences Ltd |
4 Q |
92.6% |
-57.5% |
-95.85% |
- |
| Innovation1 Biotech Inc |
3 Q |
- |
- |
- |
-3806.7% |
| Nature s Sunshine Products inc |
2 Q |
71.79% |
1.35% |
-8.26% |
10.49% |
| Nascent Biotech Inc |
1 Q |
- |
- |
- |
- |
| Nabriva Therapeutics Plc |
2 Q |
-304.55% |
-537.76% |
14.89% |
-2673.17% |
| Neubase Therapeutics inc |
3 Q |
- |
- |
- |
-103.52% |
| Nanobiotix S a |
4 Q |
- |
-109.65% |
- |
- |
| Novabay Pharmaceuticals Inc |
2 Q |
66.33% |
-66.04% |
-44.67% |
-487.2% |
| Nucana Plc |
4 Q |
- |
- |
- |
-105.28% |
| Neptune Wellness Solutions Inc |
4 Q |
13.62% |
-252.25% |
-46.29% |
- |
| Minerva Neurosciences Inc |
3 Q |
- |
- |
- |
- |
| Neximmune Inc |
2 Q |
- |
- |
- |
-542.45% |
| Ngm Biopharmaceuticals Inc |
4 Q |
- |
-16769.7% |
- |
-77.85% |
| Neurogene Inc |
2 Q |
- |
-1999.14% |
-4227.89% |
0% |
| Nektar Therapeutics |
3 Q |
48.51% |
-189.85% |
58.78% |
-121.87% |
| Nkarta Inc |
3 Q |
- |
- |
- |
-36.69% |
| Nls Pharmaceutics Ltd |
4 Q |
- |
- |
- |
- |
| 9 Meters Biopharma Inc |
1 Q |
- |
- |
- |
-584.98% |
| Nanomix Corp |
4 Q |
- |
- |
- |
- |
| Nanoviricides inc |
2 Q |
- |
- |
- |
-69.79% |
| Novan Inc |
1 Q |
59.41% |
-445.96% |
-5.62% |
-616.76% |
| Neurobo Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-154.04% |
| Nurix Therapeutics Inc |
3 Q |
- |
-388.91% |
-140.98% |
-63.39% |
| Neurosense Therapeutics Ltd |
4 Q |
- |
- |
- |
- |
| Nrx Pharmaceuticals Inc |
2 Q |
- |
- |
- |
- |
| Rebus Holdings Inc |
2 Q |
- |
- |
- |
- |
| Notable Labs Ltd |
2 Q |
- |
-260950% |
-202200% |
-182.14% |
| Nexttrip Inc |
2 Q |
8.06% |
-1048.09% |
-152.09% |
79.77% |
| Nuvation Bio Inc |
3 Q |
- |
- |
- |
-13.09% |
| Nuvalent Inc |
3 Q |
- |
- |
- |
-26.46% |
| Nuvectis Pharma inc |
1 Q |
- |
- |
- |
-118.24% |
| Novartis Ag |
4 Q |
73.27% |
31.83% |
26.59% |
31.77% |
| Northwest Biotherapeutics inc |
2 Q |
- |
-3590.2% |
79.02% |
- |
| Nexien Biopharma Inc |
1 Q |
- |
- |
- |
- |
| Nextcure Inc |
2 Q |
- |
- |
- |
-57.63% |
| Theralink Technologies Inc |
4 Q |
36.93% |
-22688.34% |
-1159.89% |
- |
| Obseva Sa |
4 Q |
- |
-107.3% |
-255.45% |
0% |
| Ocean Biomedical Inc |
3 Q |
- |
- |
- |
- |
| Oculis Holding Ag |
4 Q |
- |
-4243.2% |
0% |
- |
| Ocular Therapeutix Inc |
2 Q |
90.82% |
-266.27% |
-142.01% |
-62.56% |
| Ocuphire Pharma Inc |
2 Q |
- |
-698.29% |
-517.27% |
-32.68% |
| Oragenics Inc |
1 Q |
- |
- |
- |
-151.42% |
| Organigram Holdings Inc |
3 Q |
21.65% |
-9.8% |
0% |
-5.26% |
| Organon and Co |
2 Q |
58.43% |
12.13% |
8.03% |
- |
| Olema Pharmaceuticals inc |
3 Q |
- |
- |
- |
-47.48% |
| Omeros Corporation |
2 Q |
- |
- |
- |
- |
| Oncorus Inc |
1 Q |
- |
- |
- |
-134.31% |
| Oncosec Medical Incorporated |
4 Q |
- |
- |
- |
-868.37% |
| Oncternal Therapeutics Inc |
3 Q |
- |
-5509.5% |
-506.7% |
-85.29% |
| Oncolytics Biotech Inc |
4 Q |
- |
- |
- |
-100.69% |
| Opko Health Inc |
2 Q |
41.23% |
-5.66% |
-19.25% |
-13.95% |
| Opiant Pharmaceuticals Inc |
3 Q |
- |
-5703.35% |
-2759.19% |
-97.18% |
| Optinose Inc |
2 Q |
90.33% |
-37% |
- |
- |
| Organogenesis Holdings Inc |
3 Q |
76.24% |
2.92% |
8.58% |
4.45% |
| Orgenesis Inc |
1 Q |
-248.94% |
- |
-634.75% |
- |
| Oric Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-39.61% |
| Oramed Pharmaceuticals Inc |
2 Q |
- |
- |
- |
9.57% |
| Os Therapies Incoporated |
2 Q |
- |
- |
- |
- |
| Otonomy Inc |
3 Q |
- |
- |
- |
-137.86% |
| Oncotelic Therapeutics Inc |
2 Q |
- |
- |
- |
-12.95% |
| Ovid Therapeutics Inc |
2 Q |
- |
- |
-637.87% |
-33.4% |
| One World Products Inc |
2 Q |
81.74% |
-70173.44% |
- |
- |
| Phibro Animal Health Corporation |
2 Q |
31.79% |
0.27% |
7.44% |
0.9% |
| Prestige Consumer Healthcare Inc |
2 Q |
54.69% |
40.25% |
-4.57% |
29.1% |
| Panbela Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Psyence Biomedical ltd |
1 Q |
0% |
-7420807.66% |
- |
- |
| Puma Biotechnology Inc |
2 Q |
77.36% |
-9.62% |
-20.39% |
-3.37% |
| Rapid Therapeutic Science Laboratories Inc |
2 Q |
- |
- |
- |
- |
| Pacira Biosciences inc |
2 Q |
75.14% |
10.61% |
35.39% |
7.56% |
| Processa Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-93.83% |
| Procyon Corporation |
1 Q |
78.24% |
-8.58% |
4.78% |
-15.15% |
| Pds Biotechnology Corp |
2 Q |
- |
- |
- |
-137.06% |
| Pepgen Inc |
3 Q |
- |
- |
- |
-47.97% |
| Pfizer Inc |
2 Q |
75.16% |
0.36% |
2.58% |
-2.8% |
| Precigen Inc |
2 Q |
-41.42% |
-8199.72% |
-1134.59% |
-133.26% |
| Pharming Group N v |
4 Q |
89.8% |
-4.3% |
83.7% |
-4.82% |
| Phasebio Pharmaceuticals Inc. |
2 Q |
- |
-8012.02% |
-5232.69% |
- |
| Phathom Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Phio Pharmaceuticals Corp |
2 Q |
- |
- |
- |
-142.68% |
| Pharvaris N v |
4 Q |
- |
- |
- |
-28.63% |
| Pieris Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-97.28% |
| Peak Pharmaceuticals Inc |
4 Q |
- |
- |
- |
- |
| Protokinetix Incorporated |
2 Q |
- |
- |
- |
-87.94% |
| Pliant Therapeutics Inc |
2 Q |
- |
- |
- |
-39.76% |
| Plx Pharma Inc |
3 Q |
-278.24% |
-2201.3% |
-2563.73% |
-114.93% |
| Promis Neurosciences inc |
2 Q |
- |
- |
- |
-587.36% |
| Pmv Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-31.15% |
| Point Biopharma Global Inc |
3 Q |
- |
-887.97% |
-1279.07% |
21.1% |
| Purple Biotech Ltd |
4 Q |
- |
- |
- |
46.2% |
| Propanc Biopharma Inc |
2 Q |
- |
- |
- |
- |
| Praxis Precision Medicines Inc |
2 Q |
- |
-9153.22% |
-1915.13% |
-61.47% |
| Pardes Biosciences Inc |
2 Q |
- |
- |
- |
-43.36% |
| Perrigo Company Plc |
2 Q |
37.07% |
-10.18% |
-10.87% |
-2.66% |
| Prelude Therapeutics Inc |
3 Q |
- |
- |
- |
-14.66% |
| Procaps Group S a |
4 Q |
58.44% |
10.38% |
0% |
- |
| Prophase Labs Inc |
2 Q |
-31.23% |
-403.74% |
41.27% |
-54.04% |
| Proqr Therapeutics N v |
4 Q |
- |
- |
- |
0% |
| Prothena Corporation Public Limited Company |
2 Q |
- |
50.67% |
12.32% |
-9% |
| Puretech Health Plc |
4 Q |
- |
-2000.84% |
- |
-14.54% |
| Portage Biotech Inc |
1 Q |
- |
- |
- |
-2264.4% |
| Paratek Pharmaceuticals Inc |
1 Q |
80.01% |
-64.49% |
34.51% |
- |
| Provention Bio Inc |
4 Q |
- |
-307.75% |
-539.56% |
-103.36% |
| Ptc Therapeutics inc |
1 Q |
- |
-43.58% |
-21.73% |
- |
| Protagonist Therapeutics inc |
2 Q |
- |
-734.73% |
- |
39.06% |
| Protagenic Therapeutics Inc new |
2 Q |
- |
- |
- |
-238.37% |
| Palatin Technologies Inc |
2 Q |
- |
-2162.29% |
-139.05% |
- |
| Petros Pharmaceuticals inc |
3 Q |
75.61% |
-271.67% |
- |
- |
| Pulmatrix Inc |
1 Q |
- |
14.02% |
-48.82% |
-44.05% |
| Provectus Biopharmaceuticals Inc |
1 Q |
- |
-211.72% |
-110.91% |
- |
| Powerup Acquisition Corp |
2 Q |
- |
- |
- |
- |
| Paxmedica Inc |
2 Q |
- |
- |
- |
-3167.06% |
| Pyxis Oncology Inc |
3 Q |
- |
- |
- |
-63.26% |
| Q Biomed inc |
1 Q |
- |
- |
- |
- |
| Qualigen Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Qilian International Holding Group Limited |
3 Q |
3.83% |
-17.75% |
1.62% |
-18.31% |
| Quoin Pharmaceuticals Ltd |
2 Q |
- |
-90676.76% |
- |
-175.03% |
| Uniqure N v |
2 Q |
97.9% |
-506.01% |
- |
-129.32% |
| Rain Oncology Inc |
3 Q |
- |
- |
- |
-82.96% |
| Rani Therapeutics Holdings Inc |
3 Q |
- |
- |
- |
-130.24% |
| Rapt Therapeutics Inc |
3 Q |
- |
- |
- |
-51.96% |
| Ultragenyx Pharmaceutical Inc |
3 Q |
88.79% |
-162.82% |
-29.64% |
-346.34% |
| Actavia Life Sciences Inc |
1 Q |
- |
- |
- |
- |
| Rocket Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-53.4% |
| Arcus Biosciences Inc |
2 Q |
- |
-238.46% |
-74.36% |
-42.86% |
| Redhill Biopharma Ltd |
4 Q |
47.03% |
- |
- |
1155.92% |
| Dr Reddy s Laboratories Limited |
1 Q |
58.6% |
19.94% |
0% |
19.85% |
| Regeneron Pharmaceuticals Inc |
2 Q |
92.73% |
40.38% |
-19.22% |
16.3% |
| Renovaro Inc |
2 Q |
- |
- |
- |
-90.43% |
| Reata Pharmaceuticals Inc |
2 Q |
- |
- |
-158.7% |
- |
| Revelation Biosciences Inc |
3 Q |
- |
- |
- |
11.18% |
| Regen Biopharma Inc |
2 Q |
- |
-198.27% |
-27.54% |
- |
| Regulus Therapeutics Inc |
2 Q |
- |
- |
- |
-51.25% |
| Regenerx Biopharmaceuticals inc |
1 Q |
- |
-2007.3% |
-986.62% |
- |
| Rigel Pharmaceuticals Inc |
2 Q |
92.38% |
-2.8% |
28.44% |
- |
| Relmada Therapeutics Inc |
2 Q |
- |
- |
- |
-100.58% |
| Rallybio Corporation |
2 Q |
- |
-5430.1% |
-879.6% |
-74.08% |
| Rockwell Medical inc |
2 Q |
17.81% |
1.34% |
20.43% |
-34.93% |
| Avidity Biosciences Inc |
1 Q |
- |
-1943.41% |
- |
-37.98% |
| Cartesian Therapeutics Inc |
2 Q |
- |
28.79% |
-47.54% |
- |
| Transcode Therapeutics Inc |
2 Q |
- |
- |
- |
-597.47% |
| Renovorx Inc |
2 Q |
- |
- |
- |
-403.38% |
| Roivant Sciences Ltd |
2 Q |
- |
- |
-1554.72% |
91.17% |
| Reneo Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-62.08% |
| Royalty Pharma Plc |
2 Q |
60.46% |
36.18% |
- |
10.49% |
| Repare Therapeutics Inc |
3 Q |
- |
-874.43% |
-378.65% |
-38.6% |
| Respirerx Pharmaceuticals Inc |
2 Q |
- |
- |
- |
- |
| Rvl Pharmaceuticals Plc |
2 Q |
86.32% |
-326.71% |
-184.37% |
-155.18% |
| Revance Therapeutics Inc |
2 Q |
73.03% |
-57.31% |
-78.65% |
- |
| Reviva Pharmaceuticals Holdings Inc |
2 Q |
- |
- |
- |
- |
| Prometheus Biosciences Inc |
1 Q |
- |
-3699.19% |
-19388.87% |
-33.5% |
| Rhythm Pharmaceuticals inc |
2 Q |
89.87% |
-115.42% |
- |
-221.19% |
| Rayzebio Inc |
3 Q |
- |
- |
- |
- |
| Rezolute Inc |
2 Q |
- |
- |
- |
-70.73% |
| Sage Therapeutics Inc |
3 Q |
66.68% |
-7423.78% |
- |
-62.67% |
| Cassava Sciences Inc |
2 Q |
- |
- |
- |
20.29% |
| Sunshine Biopharma Inc |
2 Q |
25.33% |
-5.31% |
-55.34% |
-16.09% |
| Scpharmaceuticals Inc |
3 Q |
71.58% |
-411.85% |
-956.48% |
-77.06% |
| Scopus Biopharma Inc |
2 Q |
- |
- |
- |
- |
| Scorpius Holdings inc |
2 Q |
-10.26% |
-1221.63% |
-10.89% |
0% |
| Societal Cdmo Inc |
3 Q |
15.77% |
-19.47% |
14.64% |
-37.93% |
| Scynexis Inc |
3 Q |
- |
-99.77% |
-788.64% |
182.33% |
| Schrodinger Inc |
2 Q |
67.63% |
-116.64% |
-48.64% |
-38.38% |
| Seelos Therapeutics inc |
2 Q |
- |
- |
-61.17% |
- |
| Serina Therapeutics Inc |
1 Q |
- |
-188740% |
- |
- |
| Sangui Biotech International Inc |
1 Q |
- |
-205.74% |
-12.47% |
- |
| Sagimet Biosciences inc |
2 Q |
- |
- |
- |
-25.5% |
| Sigilon Therapeutics Inc |
2 Q |
- |
-127.22% |
-366.66% |
-83.83% |
| Shuttle Pharmaceuticals Holdings Inc |
2 Q |
- |
- |
- |
-217.58% |
| Siga Technologies Inc |
2 Q |
43.55% |
8.4% |
-169.27% |
51.39% |
| Silo Pharma Inc |
2 Q |
91.91% |
-5169.37% |
- |
-50.39% |
| Sio Gene Therapies Inc |
4 Q |
- |
- |
- |
-55.94% |
| Skinvisible Inc |
2 Q |
- |
-6068.98% |
-22.14% |
- |
| Skye Bioscience Inc |
2 Q |
- |
- |
- |
-112.58% |
| Sol gel Technologies Ltd |
4 Q |
- |
-1752.77% |
- |
-70.48% |
| Acelyrin Inc |
2 Q |
- |
- |
- |
-46.1% |
| Salarius Pharmaceuticals inc |
2 Q |
- |
- |
- |
-148.64% |
| Sellas Life Sciences Group Inc |
2 Q |
- |
- |
- |
-17349.62% |
| Summit Therapeutics Inc |
2 Q |
- |
- |
- |
-155.34% |
| Syndax Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-42.37% |
| Soligenix inc |
2 Q |
0% |
-70217.85% |
- |
-256.63% |
| Sonoma Pharmaceuticals Inc |
2 Q |
38.51% |
-33.71% |
-15.9% |
-77.69% |
| Synaptogenix Inc |
2 Q |
- |
- |
- |
-101.07% |
| Sensei Biotherapeutics Inc |
3 Q |
- |
- |
- |
-44.68% |
| Sanofi |
4 Q |
69.35% |
11.7% |
21.74% |
7.31% |
| Sonnet Biotherapeutics Holdings Inc |
2 Q |
- |
- |
- |
-681.02% |
| Spectrum Pharmaceuticals Inc |
1 Q |
93.19% |
-32.07% |
76.88% |
-209.59% |
| Spruce Biosciences Inc |
3 Q |
- |
-402.02% |
42.92% |
-54.81% |
| Scisparc Ltd |
4 Q |
76.28% |
- |
67.59% |
61.36% |
| Spero Therapeutics Inc |
3 Q |
- |
-12.58% |
63.34% |
-2.59% |
| Ars Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-7.83% |
| Sarepta Therapeutics Inc |
3 Q |
- |
-12.34% |
-93.39% |
-106.15% |
| Sierra Oncology Inc |
1 Q |
- |
- |
- |
-76.49% |
| Statera Biopharma Inc fka Cytocom Inc |
3 Q |
74.74% |
-500.68% |
0% |
- |
| Stoke Therapeutics Inc |
3 Q |
- |
-741.9% |
-62.97% |
-54.29% |
| Satsuma Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-115.24% |
| Shattuck Labs Inc |
2 Q |
- |
-1339.47% |
-951.65% |
-72.51% |
| Supernus Pharmaceuticals inc |
2 Q |
89.36% |
11.83% |
-6.72% |
0.35% |
| Sunwin Stevia International Inc. |
2 Q |
14.99% |
-2.52% |
8.06% |
-106.36% |
| Sinovac Biotech Ltd |
4 Q |
54.15% |
5.9% |
- |
0.69% |
| Savara Inc |
3 Q |
- |
- |
- |
-44.42% |
| 60 Degrees Pharmaceuticals Inc |
2 Q |
28.33% |
-3340.13% |
-256.13% |
- |
| Synlogic Inc |
3 Q |
- |
-3073.28% |
-5527.99% |
-95.3% |
| Spyre Therapeutics Inc |
2 Q |
- |
- |
- |
0% |
| Syros Pharmaceuticals Inc |
3 Q |
- |
-1067.07% |
-85.67% |
-122.04% |
| Takeda Pharmaceutical Company Limited |
1 Q |
66.54% |
3.38% |
19.68% |
1.98% |
| Taro Pharmaceutical Industries Ltd |
1 Q |
46.83% |
4.44% |
16.03% |
1.47% |
| Theravance Biopharma inc |
2 Q |
- |
-115.94% |
-52.54% |
-22.83% |
| Tricida Inc |
3 Q |
- |
- |
- |
- |
| Alaunos Therapeutics Inc |
3 Q |
- |
- |
- |
-140.74% |
| Telomir Pharmaceuticals Inc |
2 Q |
- |
- |
- |
- |
| Tenx Keane Acquisition |
1 Q |
- |
- |
- |
- |
| Tenax Therapeutics Inc |
2 Q |
- |
- |
- |
123.59% |
| Terns Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-30.99% |
| Teva Pharmaceutical Industries Limited |
2 Q |
48.61% |
-20.99% |
-17.6% |
-10.38% |
| Tff Pharmaceuticals Inc |
2 Q |
- |
-688.88% |
- |
-211.48% |
| Tg Therapeutics Inc |
2 Q |
88.7% |
9.36% |
10.12% |
46.04% |
| Tharimmune Inc |
4 Q |
- |
- |
- |
-171.08% |
| Third Harmonic Bio Inc |
3 Q |
- |
- |
- |
5.62% |
| Thorne Healthtech Inc |
2 Q |
55.89% |
5.96% |
0.87% |
13.58% |
| Theseus Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-24.84% |
| Theratechnologies Inc |
4 Q |
75.99% |
-29.3% |
47.69% |
- |
| Talphera Inc |
2 Q |
- |
- |
- |
0% |
| Tiziana Life Sciences Ltd |
4 Q |
- |
- |
- |
-319.56% |
| Timber Pharmaceuticals Inc |
2 Q |
- |
-29367.95% |
-19196.18% |
-516.88% |
| Tango Therapeutics Inc |
3 Q |
- |
-207.45% |
-70.06% |
-41.41% |
| Tonix Pharmaceuticals Holding Corp |
2 Q |
-52.49% |
-3567.75% |
-131.02% |
-162.54% |
| Theriva Biologics inc |
1 Q |
- |
- |
- |
-49.88% |
| Tempest Therapeutics Inc |
3 Q |
- |
- |
- |
-378.21% |
| Turning Point Therapeutics Inc. |
2 Q |
- |
-103435.29% |
-16289.92% |
-37.45% |
| Traws Pharma inc |
1 Q |
- |
-8898.21% |
-7912.5% |
-126.77% |
| Entrada Therapeutics Inc |
2 Q |
- |
- |
- |
62.08% |
| Trevi Therapeutics Inc |
3 Q |
- |
- |
- |
-27.17% |
| Trevena inc |
2 Q |
- |
- |
- |
- |
| 2seventy Bio Inc |
2 Q |
- |
- |
- |
-62.25% |
| Travere Therapeutics Inc |
2 Q |
96.19% |
-130.11% |
-20.25% |
-102.43% |
| Therapeuticsmd Inc |
1 Q |
97.86% |
-465.81% |
- |
-35.26% |
| Neuropathix Inc. |
1 Q |
- |
-767.19% |
41.6% |
- |
| Tyme Technologies Inc. |
2 Q |
- |
- |
- |
-29.11% |
| Tyra Biosciences Inc |
3 Q |
- |
- |
- |
-24.48% |
| Unity Biotechnology Inc |
3 Q |
- |
- |
- |
-94.34% |
| Unicycive Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Universe Pharmaceuticals Inc |
3 Q |
31.93% |
-19.08% |
-7.32% |
-15.59% |
| Urogen Pharma Ltd |
2 Q |
90.75% |
-154.51% |
- |
- |
| United Therapeutics Corporation |
2 Q |
89.12% |
38.9% |
14.58% |
18.82% |
| Avricore Health Inc |
4 Q |
47.97% |
-27.95% |
12.07% |
-34.9% |
| Vaxxinity Inc |
4 Q |
- |
- |
- |
-243.89% |
| Vbi Vaccines Inc |
1 Q |
- |
-1474.46% |
-913.51% |
-1094.9% |
| Vaccinex Inc |
3 Q |
- |
-24560% |
-8905% |
0% |
| Vera Therapeutics Inc |
3 Q |
- |
- |
- |
-82.41% |
| Veru Inc |
2 Q |
40.08% |
-4.87% |
-167.38% |
-76.11% |
| Verve Therapeutics Inc |
3 Q |
- |
-1468.01% |
- |
-38.83% |
| Viveon Health Acquisition Corp |
1 Q |
- |
- |
- |
- |
| Vincerx Pharma Inc |
2 Q |
- |
- |
- |
-276.65% |
| Virios Therapeutics inc |
2 Q |
- |
- |
- |
-98.74% |
| Viracta Therapeutics Inc |
3 Q |
- |
- |
- |
-150.26% |
| Viking Therapeutics Inc |
3 Q |
- |
- |
- |
-31.28% |
| Vanda Pharmaceuticals Inc |
2 Q |
94.59% |
-8.95% |
-43.99% |
-2.01% |
| Verrica Pharmaceuticals Inc |
3 Q |
- |
-850.26% |
- |
-95.39% |
| Verona Pharma Plc |
2 Q |
- |
- |
- |
-55.38% |
| Virpax Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-426.36% |
| Vertex Pharmaceuticals Inc |
2 Q |
85.94% |
-135.83% |
-173.06% |
-2.91% |
| Verastem Inc |
2 Q |
- |
-82.56% |
10.18% |
-194.05% |
| Vistagen Therapeutics Inc |
2 Q |
- |
-12777.38% |
-19342.86% |
-35.12% |
| Viatris Inc |
2 Q |
38.07% |
-8.6% |
-2.57% |
-3.2% |
| Vtv Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Ventyx Biosciences Inc |
3 Q |
- |
- |
- |
-54.28% |
| Vyne Therapeutics Inc |
2 Q |
- |
-4750.51% |
- |
-43.99% |
| Wellness Center Usa Inc |
2 Q |
90.33% |
-689.92% |
-20.87% |
- |
| Wave Life Sciences Ltd |
3 Q |
- |
14.74% |
-67.09% |
- |
| Xenetic Biosciences Inc |
2 Q |
- |
-175.38% |
-72.29% |
-47.06% |
| Xbiotech Inc |
2 Q |
- |
- |
- |
-16.52% |
| Exicure Inc |
2 Q |
- |
- |
- |
-288.03% |
| Xenon Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-25.99% |
| Xeris Biopharma Holdings Inc |
2 Q |
83.79% |
-1.56% |
-10.58% |
- |
| Xilio Therapeutics inc |
2 Q |
- |
-590.79% |
- |
-176.51% |
| Xencor Inc |
2 Q |
- |
-397.45% |
-1.56% |
-28.6% |
| Xoma Royalty Corporation |
2 Q |
- |
92.22% |
67.82% |
-31.26% |
| Xortx Therapeutics inc |
4 Q |
- |
-234.7% |
14.27% |
-16.83% |
| Novaccess Global Inc |
1 Q |
- |
- |
- |
- |
| Xtl Biopharmaceuticals Ltd |
4 Q |
- |
- |
- |
-35.23% |
| Y mabs Therapeutics inc |
2 Q |
86.78% |
-40.57% |
9.02% |
-29.98% |
| Zai Lab Limited |
2 Q |
99.92% |
-79.87% |
-20.63% |
-37.96% |
| Zentalis Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-44.24% |
| Zomedica Corp |
2 Q |
81.35% |
-446.31% |
-54.96% |
-23.79% |
| Zosano Pharma Corporation |
1 Q |
34.85% |
-25309.85% |
- |
-172.07% |
| Zoetis Inc |
2 Q |
71.71% |
26.43% |
-16.98% |
46.66% |
| Zevra Therapeutics Inc |
2 Q |
19.69% |
-447.85% |
-80.67% |
-124.85% |
| Zyversa Therapeutics Inc |
1 Q |
- |
- |
- |
-46.45% |
| Zymeworks Inc |
2 Q |
- |
-195.84% |
-227.88% |
-25.96% |
| Zynerba Pharmaceuticals Inc |
2 Q |
- |
- |
- |
-90.03% |
